Genelux Corp
Genelux Corp (GNLX) Option Chain
As of September 23, 2026, Genelux Corp is trading at $2.52, a -3.64% change from the previous close. The nearest expiration is Oct 16, 2026. Implied volatility is 399.3%. IV Rank is 72%.
Read more
Tracking the GNLX option chain helps you see every strike and expiry on Genelux Corp in one view, so you can quickly identify the contracts that fit your thesis and your risk. Genelux Corp's option chain lays out bids, asks, volume, open interest, and Greeks across calls and puts, giving you the full map of GNLX options activity at a glance. Use our scanner to monitor the GNLX option chain in real time and filter for the GNLX options trades that actually meet your criteria.
An option chain is the complete listing of all available option contracts on an underlying, organized by expiration date and strike price. For GNLX stock options, the chain shows side-by-side call and put data, making it easy to compare premiums, assess liquidity, and spot pricing dislocations. Reading the GNLX option chain effectively means looking beyond the last price — implied volatility by strike, volume-to-open-interest ratios, and bid-ask spreads all tell you where GNLX stock options are being actively traded and where they are not.
Genelux Corporation, a clinical-stage biopharmaceutical company, focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive and/or difficult-to-treat solid tumor types. Its lead product candidate is Olvi-Vec, a proprietary, modified strain of the vaccinia virus for the treatment of ovarian cancer and non-small-cell lung cancer. The company is also developing V2ACT Immunotherapy for the treatment of pancreatic cancer; and V-VET1 to treat hematologic and solid cancer. The company was incorporated in 2001 and is headquartered in Westlake Village, California.
Credit spreads, long calls, iron condors, calendar trades — every strategy starts with the same raw material: a clean, complete option chain. Our scanner pulls Genelux Corp's full chain across every expiry, highlights the most liquid strikes, and lets you screen GNLX options by the metrics that matter, from IV skew to volume surges. Stop scrolling through endless rows of GNLX stock options — let the full option chain come to you, pre-filtered and ready to trade.
Stock Statistics
- IndustryBiotechnology
- SectorHealthcare
- IV percentile77.38% Elevated
- Market cap (M$)114
- 52 weeks high-70.49%
- 52 weeks low10.04%
- Analyst recommendationStrong Buy
1.00 - Target price$18.83
647.22% above the current stock price - Dividend—
- Payout ratio—
- Earnings date2026-11-04
- P/E—
- Future P/E—
- EPS (ttm)-0.87
- EPS growth next 5 years44.13%
As of September 23, 2026
| CALLs | PUTs | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Prob. OTM % | Open Interest | Volume | Extrinsic Value | Intrinsic Value | Bid | Ask | Strike | Moneyness % | Bid | Ask | Intrinsic Value | Extrinsic Value | Volume | Open Interest | Prob. OTM % |
| 68.71 | 4 | 0 | 3.78 | 0.02 | — | 3.80 | 2.50 | -0.79 | — | 3.70 | 0.00 | 3.70 | 0 | 251 | 31.29 |
| 88.17 | 46 | 0 | 0.55 | 0.00 | — | 0.55 | 5.00 | +98.41 | — | 3.30 | 2.48 | 0.82 | 0 | 0 | 11.83 |
| 94.41 | 4 | 0 | 0.95 | 0.00 | — | 0.95 | 7.50 | +197.62 | 3.30 | 7.40 | 4.98 | 0.37 | 0 | 0 | 5.59 |
As of September 23, 2026
Scan the full option chain in one place
Browse the full GNLX option chain across every strike and expiration, filter by IV, volume, and open interest, and evaluate your trade without switching tools.
Start your 14-day free trial→